Under construction – not a live service
Sign in
CompletedNo phase

Hidradenitis Suppurativa Mail Survey

Key facts

Who runs it
Wake Forest University Health Sciences
Where
Winston-Salem, United StatesSee the site
Trial code
Status
Completed
People taking part
67 people enrolled
Started
14 May 2018
Ended
22 Jan 2025
Type of study
Observational
Record updated
26 November 2025

Who can take part

Age
18 years and older
Sex
Women and men

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Patients diagnosed with Hidradenitis Suppurativa by a dermatologist at Wake Forest Baptist Medical Center's dermatology clinic
  • Patients 18 years of age or older

Who cannot take part

  • Patients younger than 18 years of age
  • Any patient who does not have a mailing address on file

Where in United States

  • Wake Forest Baptist Medical CenterWinston-Salem, United StatesNo longer taking part

About the trial

What the trial wants to find out

Hidradenitis Suppurativa (HS), also known as "acne inversa," is a chronic dermatologic disease affecting apocrine gland-bearing areas and presenting with symptoms ranging from pustules and inflammatory nodules to draining sinuses, abscesses, and fistulae. The pain and odorous lesions associated with HS contribute to its heightened impact on quality of life in comparison to other diseases; it has been described as "one of the most distressing conditions observed in dermatology." Though it is clear that HS has a significant impact on quality of life, how this manifests remains poorly characterized. The aim of this study is to characterize the quality of life impact of HS and to validate a tool for patients to self-assess the severity of their condition.

The group in the trial

  • Patients with HS

    The set of all Hidradenitis Suppurativa patients (ICD-10 code: L73.2) who visited Wake Forest Baptist Medical Center's dermatology clinic during the last 5 years will either be recruited in person or be mailed the HS Severity Self-Assessment tool and a survey about their demographics, symptoms, treatments, psychological aspects, and lifestyle.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Record updated
26 November 2025